Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026)
Elutia recorded quarterly Depreciation & Amortization (CF) of $330000.0 in Q1 2026, up 11.11% quarter-over-quarter from $297000.0 in Q4 2025, and down 61.98% year-over-year from $868000.0 in Q1 2025.
Elutia's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $330000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 61.98% year-over-year to $330000.0; the TTM figure through Mar 2026 stood at $2.2 million (down 34.96% YoY), while the FY2025 annual figure was $2.8 million, down 19.3% from the prior year.
- Depreciation & Amortization (CF) came in at $330000.0 for Q1 2026 at Elutia, up from $297000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $954000.0 in Q2 2023 to a low of $297000.0 in Q4 2025.
- A 5-year average of $826294.1 and a median of $892000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 3.48% in 2025 and fell as far as 65.59% in 2025.
- Elutia's Depreciation & Amortization (CF) stood at $937000.0 in 2022, then declined by 4.59% to $894000.0 in 2023, then declined by 3.47% to $863000.0 in 2024, then tumbled by 65.59% to $297000.0 in 2025, then increased by 11.11% to $330000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $330000.0, $297000.0, and $728000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 894,000.00 |
| Dec 31, 2023 | 894,000.00 |
| Sep 30, 2023 | 953,000.00 |
| Sep 30, 2023 | 953,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Mar 31, 2023 | 947,000.00 |
| Mar 31, 2023 | 947,000.00 |
| Dec 31, 2022 | 937,000.00 |
| Dec 31, 2022 | 937,000.00 |
| Sep 30, 2022 | 933,000.00 |
| Sep 30, 2022 | 933,000.00 |
| Jun 30, 2022 | 934,000.00 |
| Jun 30, 2022 | 934,000.00 |
| Mar 31, 2022 | 929,000.00 |
| Mar 31, 2022 | 929,000.00 |
| Dec 31, 2021 | 933,000.00 |
| Dec 31, 2021 | 933,000.00 |
| Sep 30, 2021 | 932,000.00 |
| Sep 30, 2021 | 932,000.00 |
| Jun 30, 2021 | 932,000.00 |
| Jun 30, 2021 | 932,000.00 |
| Mar 31, 2021 | 933,000.00 |
| Mar 31, 2021 | 933,000.00 |
| Dec 31, 2020 | 943,000.00 |
| Dec 31, 2020 | 943,000.00 |
| Sep 30, 2020 | 972,000.00 |
| Sep 30, 2020 | 972,000.00 |
| Jun 30, 2020 | 975,000.00 |
| Jun 30, 2020 | 975,000.00 |
| Mar 31, 2020 | 974,000.00 |
| Mar 31, 2020 | 974,000.00 |
| Dec 31, 2019 | 970,000.00 |
| Dec 31, 2019 | 970,000.00 |